Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Neuro Endocrinology Letters|April 29, 2010
Individual clearance and therapeutic drug monitoring of quetiapine in clinical practiceMarkus Wittmann, Helmut Hausner, Anton Köstlbacher, et al.
Journal of Clinical Psychopharmacology|August 14, 2018
How to Treat Hypertension in Venlafaxine-Medicated Patients-Pharmacokinetic Considerations in Prescribing Amlodipine and RamiprilMarc Augustin, Georgios Schoretsanitis, Gerhard Gründer, et al.
Psychiatrische Praxis|October 22, 2008
[Psychopharmacoepidemiology: differences in prescribing strategies in the inpatient and outpatient settings]Helmut Hausner, Markus Wittmann, Ekkehard Haen, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|May 9, 2015
[Hyperkinetic disorders in childhood and adolescence- an analysis of KinderAGATE 2009-2012]Benedikt Stegmann, Christian A Rexroth, Katharina Wenzel-Seifert, et al.
Therapeutic Drug Monitoring|May 9, 2025
Nifedipine May Be an Inhibitor of Clozapine Metabolism as Seen in 5 Patients: 2 From a US Double-Blind Study and 3 From a German Therapeutic Drug Monitoring StudyGeorgios Schoretsanitis, Ekkehard Haen, Hélène Verdoux, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 28, 2018
Reduced clearance of venlafaxine in a combined treatment with quetiapineMichael Paulzen, Georgios Schoretsanitis, Christoph Hiemke, et al.
Psychiatrische Praxis|December 1, 2004
[Genetic tau-variants in patients with frontotemporal dementia]Bernd Ibach, Markus Wittmann, Frank Pfannenschmid, et al.
Pharmaceutics|February 26, 2025
Physiologically Based Pharmacokinetic Model of CYP2D6 Associated Interaction Between Venlafaxine and Strong Inhibitor Bupropion-The Influence of Age-Relevant Changes and Inhibitory Dose to Classify Therapeutical Success and HarmUlrich Ruben Luecht, Wolfgang Scholz, Ann-Kathrin Geiben, et al.
The Journal of Clinical Psychiatry|September 8, 2018
Differences in Duloxetine Dosing Strategies in Smoking and Nonsmoking Patients: Therapeutic Drug Monitoring Uncovers the Impact on Drug MetabolismMarc Augustin, Georgios Schoretsanitis, Christoph Hiemke, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 29, 2011
Interactions of recombinant human histamine H₁R, H₂R, H₃R, and H₄R receptors with 34 antidepressants and antipsychoticsHeidrun Appl, Tobias Holzammer, Stefan Dove, et al.
Pageof 8